stockrowGenerate Biomedicines, Inc. (GENB) vs Stoke Therapeutics, Inc. (STOK)
- Generate Biomedicines, Inc. GENB 13.06 +3.90%
- Stoke Therapeutics, Inc. STOK 26.54 +1.80%
Generate Biomedicines, Inc. and Stoke Therapeutics, Inc. are both Biotechnology companies. Generate Biomedicines, Inc. and Stoke Therapeutics, Inc. are of similar size ($1.7B and $1.6B). Generate Biomedicines, Inc. has the higher net margin (−781.1% vs −862.1%) and the higher return on invested capital (0.00% vs −482.0%). Across the 15 metrics below, Generate Biomedicines, Inc. leads on 9 and Stoke Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | GENB | STOK | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | (751.19%) | (913.12%) | 0.00% |
| Net margin | (781.10%) | (862.07%) | 0.00% |
| Free cash flow margin | (1,692.17%) | (764.66%) | 0.00% |
| Return on equity | 0.00% | (73.62%) | (51.96%) |
| Return on assets | (90.35%) | (63.42%) | (46.06%) |
| Return on invested capital | 0.00% | (482.02%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack